PT - JOURNAL ARTICLE AU - Scott, Gregory D. AU - Neilson, Lee E. AU - Woltjer, Randy AU - Quinn, Joseph F. AU - Lim, Miranda M. TI - Lifelong association of disorders related to military trauma with subsequent Parkinson’s disease AID - 10.1101/2021.08.21.21262374 DP - 2023 Jan 01 TA - medRxiv PG - 2021.08.21.21262374 4099 - http://medrxiv.org/content/early/2023/05/05/2021.08.21.21262374.short 4100 - http://medrxiv.org/content/early/2023/05/05/2021.08.21.21262374.full AB - Background Trauma-related disorders such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are emerging as risk factors for Parkinson’s Disease (PD), but their association with development of PD and independence from comorbid disorders remains unknown. This case-control study examines TBI and PTSD related to early trauma in military veterans.Methods PD was identified by ICD code, recurrent PD-specific prescriptions, and availability of 5+ years of earlier records. Validation was performed by chart review by a movement disorder-trained neurologist. Controls were matched 4:1 by age, duration of preceding health care, race, ethnicity, birth year, and sex. TBI and PTSD were identified by ICD code and onset based on active duty. Association and interaction were measured for TBI and PTSD with PD going back sixty years. Interaction was measured for comorbid disorders.Results 71,933 cases and 287,732 controls were identified. TBI and PTSD increased odds of subsequent PD at all preceding five-year intervals back to year -60 (OR range: 1.5 [1.4,1.7] to 2.1 [2.0,2.1]). TBI and PTSD showed synergism (synergy index range: 1.14 [1.09,1.29] to 1.28 [1.09,1.51]) and additive association (OR range: 2.2 [1.6,2.8] to 2.7 [2.5,2.8]). Chronic pain and migraine showed greatest synergy with PTSD and TBI. Effect sizes for trauma-related disorders were comparable to established prodromal disorders.Discussion TBI and PTSD are associated with later PD and are synergistic with chronic pain and migraine. These findings provide evidence for TBI and PTSD as risk factors preceding PD by decades and could aid in prognostic calculation and earlier intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was also supported in part by VA Biomedical Laboratory Research and Development Career Development Award Number 1 IK2 BX005760-01A1 to GS, VA Career Development Award 1IK2CX002539-01A1 to LN, and VA Clinical Science Research and Development Merit Award I01 CX002022 to MML. All authors (G.D. Scott, L. E. Neilson, R. Woltjer, J.F. Quinn, M. M. Lim) report no disclosures relevant to the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Portland VA institutional IRB approval (MIRB #04744)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAbstracted and fully de-identified data can be made available upon request with appropriate approvals.